Back

The importance of TTR rapid knockdown in ATTR-CM

9 May 2026 (14:33 - 14:43)
Organised by: Logo
Congress Presentation Part of: Targeting ATTR-CM at the source: how vutrisiran is improving outcomes for patients Cardiac Amyloidosis Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Jose Gonzalez-Costello

Bellvitge University Hospital, Hospitalet De Llobregat (Spain)

4 More presentations in this session

Presentation thumbnail
Welcome and introduction
Doctor J. Gonzalez-Costello (Hospitalet De Llobregat, ES)
Presentation thumbnail
HELIOS-B: latest data - and what this means for patient outcomes
Professor A. Bondue (Brussels, BE)
Presentation thumbnail
Vutrisiran in ATTR-CM: Experience from clinical practice
Associate Professor R. Pfister (Cologne, DE)
Presentation thumbnail
Panel discussion, audience questions and closing remarks
Doctor J. Gonzalez-Costello (Hospitalet De Llobregat, ES) Professor A. Bondue (Brussels, BE) Associate Professor R. Pfister (Cologne, DE)

Access the full session

Session thumbnail
Targeting ATTR-CM at the source: how vutrisiran is improving outcomes for patients

The Event

Event poster

Heart Failure 2026

9 May 2026 14:33 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources